The use of skin traction in the adult patients with proximal femur fracture. What are the effects, advantages and disadvantages? A scoping review

Background: Hip surgery is normally the chosen therapy for proximal femur fractures. Surgery within 24–48 h after hip fracture is recommended, but surgery may not always be performed promptly. Consequently, skin-traction is applied to reduce complications. The purpose of this review is to assess both advantages and disadvantages of skin traction. Methods: A scoping review was conducted. The research question was: which are the effects of skin traction, its advantages and disadvantages in adult patients with proximal femur fractures hospitalised in orthopaedic wards? The search was done in the databases PubMed, CINAHL, Cochrane, Embase, DOAJ, ClinicalTrials.gov and OpenDissertation. Results: 9 records were included, skin traction effects were summarised in 7 categories: pain, pressure sores, comfort and relaxation, thromboembolism, damage from adhesive, complications and quality of care. The possible advantage is pain reduction between 24 and 60 h, the possible disadvantage is skin damage. Discussion and conclusion: The routine use of skin traction does not appear recommended, but more consistent evidence is necessary to make clinic decisions. Future RCTs could focus on the effects of skin traction 24–60 h after hospitalisation and before surgery

Centers of Mass and Rotational Kinematics for the Relativistic N-Body Problem in the Rest-Frame Instant Form

In the Wigner-covariant rest-frame instant form of dynamics it is possible to develop a relativistic kinematics for the N-body problem. The Wigner hyperplanes define the intrinsic rest frame and realize the separation of the center-of-mass. Three notions of {\it external} relativistic center of mass can be defined only in terms of the {\it external} Poincar\'e group realization. Inside the Wigner hyperplane, an {\it internal} unfaithful realization of the Poincar\'e group is defined. The three concepts of {\it internal} center of mass weakly {\it coincide} and are eliminated by the rest-frame conditions. An adapted canonical basis of relative variables is found. The invariant mass is the Hamiltonian for the relative motions. In this framework we can introduce the same {\it dynamical body frames}, {\it orientation-shape} variables, {\it spin frame} and {\it canonical spin bases} for the rotational kinematics developed for the non-relativistic N-body problem.Comment: 78 pages, revtex fil

An acido-triggered reversible luminescent and nonlinear optical switch based on a substituted styrylpyridine : EFISH measurements as an unusual method to reveal a protonation-deprotonation NLO contrast

Diphenyl-(4-{2-[4-(2-pyridin-4-yl-vinyl)-phenyl]-vinyl}-phenyl)-amine (DPVPA) constitutes a novel acido-triggered reversible luminescent and nonlinear optical switch. Remarkably, for the first time the Electric-Field Induced Second Harmonic generation (EFISH) technique is used to reveal a protonation-deprotonation NLO contrast

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients

Objective:to explore the association between genetic markers and Oligoclonal Bands (OCB) in the Cerebro Spinal Fluid (CSF) of Italian Multiple Sclerosis patients.Methods:We genotyped 1115 Italian patients for HLA-DRB1*15 and HLA-A*02. In a subset of 925 patients we tested association with 52 non-HLA SNPs associated with MS susceptibility and we calculated a weighted Genetic Risk Score. Finally, we performed a Genome Wide Association Study (GWAS) with OCB status on a subset of 562 patients. The best associated SNPs of the Italian GWAS were replicated in silico in Scandinavian and Belgian populations, and meta-analyzed.Results:HLA-DRB1*15 is associated with OCB+: p = 0.03, Odds Ratio (OR) = 1.6, 95% Confidence Limits (CL) = 1.1-2.4. None of the 52 non-HLA MS susceptibility loci was associated with OCB, except one SNP (rs2546890) near IL12B gene (OR: 1.45; 1.09-1.92). The weighted Genetic Risk Score mean was significantly (p = 0.0008) higher in OCB+ (7.668) than in OCB- (7.412) patients. After meta-analysis on the three datasets (Italian, Scandinavian and Belgian) for the best associated signals resulted from the Italian GWAS, the strongest signal was a SNP (rs9320598) on chromosome 6q (p = 9.4×10-7) outside the HLA region (65 Mb).Discussion:genetic factors predispose to the development of OCB

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients

OBJECTIVE: to explore the association between genetic markers and Oligoclonal Bands (OCB) in the Cerebro Spinal Fluid (CSF) of Italian Multiple Sclerosis patients. METHODS: We genotyped 1115 Italian patients for HLA-DRB1*15 and HLA-A*02. In a subset of 925 patients we tested association with 52 non-HLA SNPs associated with MS susceptibility and we calculated a weighted Genetic Risk Score. Finally, we performed a Genome Wide Association Study (GWAS) with OCB status on a subset of 562 patients. The best associated SNPs of the Italian GWAS were replicated in silico in Scandinavian and Belgian populations, and meta-analyzed. RESULTS: HLA-DRB1*15 is associated with OCB+: p\u200a=\u200a0.03, Odds Ratio (OR)\u200a=\u200a1.6, 95% Confidence Limits (CL)\u200a=\u200a1.1-2.4. None of the 52 non-HLA MS susceptibility loci was associated with OCB, except one SNP (rs2546890) near IL12B gene (OR: 1.45; 1.09-1.92). The weighted Genetic Risk Score mean was significantly (p\u200a=\u200a0.0008) higher in OCB+ (7.668) than in OCB- (7.412) patients. After meta-analysis on the three datasets (Italian, Scandinavian and Belgian) for the best associated signals resulted from the Italian GWAS, the strongest signal was a SNP (rs9320598) on chromosome 6q (p\u200a=\u200a9.4 710(-7)) outside the HLA region (65 Mb). DISCUSSION: genetic factors predispose to the development of OCB

Effect of the Coordination to the "Os3(CO)11" Cluster Core on the Quadratic Hyperpolarizability of trans-4-(4'-X-styryl)pyridines (X = NMe2, t-Bu, CF3) and trans,trans-4-(4'-NMe2-phenyl-1,3-butadienyl)pyridine

Coordination to the \u201cOs3(CO)11\u201d cluster core of substituted styrylpyridines such as trans-4-(4\u2019-NMe2-styryl)pyridine (L1), trans-4-(4\u2019-t-Bu-styryl)pyridine (L2), trans-4-(4\u2019-CF3-styryl)-pyridine (L3), or trans,trans-4-(4\u2019-NMe2-phenyl-1,3-butadienyl)pyridine (L4) produces an enhancement of their quadratic hyperpolarizability, \u3b2 EFISH, measured by the solution-phase dc electric-field-induced second harmonic (EFISH) generation method. This effect is due either to a red-shift of the intraligand charge-transfer (ILCT) transition upon coordination (when the substituent in para position is a strong electron donor) or to a metal-to-ligand charge transfer (MLCT) transition (when the substituent is a strong electron acceptor). In the latter case the quadratic hyperpolarizability has a negative sign, due to the negative value of \u394\u3bceg. Therefore the \u201cOs3(CO)11\u201d cluster core displays an ambivalent acceptor or donor role. Some of the complexes investigated in this study show significant values (between 500x10-48 and 900x10-48 esu) of the product \u3bc\u3b20

Oral discomfort and hormone replacement therapy in the post-menopause.

We evaluated the incidence of oral discomfort in post-menopausal women and the efficacy of hormone replacement therapy in patients complaining of such symptoms. Two studies were performed. In the first, we compared oral discomfort and oral mucosa smears in 47 patients receiving replacement therapy and in 40 untreated post-menopausal women. In the second, the efficacy of hormone replacement therapy with oestriol vaginal cream (22 patients) or conjugated oestrogens plus norethisterone acetate (10 patients) was evaluated. In the first study, oral exfoliative cytology showed a similar maturation index and volume in both groups. In the second, hormone replacement therapy improved subjective and objective symptoms in 12 out of 22 patients treated with oestriol and in 7 out of 10 patients treated with conjugated oestrogens plus norethisterone. These data suggest that oestrogen deficiency can be considered a possible cause of oral discomfort in some post-menopausal patients and that oestrogen replacement therapy may improve subjective symptoms